Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep876 | Reproductive and Developmental Endocrinology | ECE2024

Correlating adiposity with metabolic disturbances in PCOS patients: a single-centre retrospective study

Thadani Puja , Leca Bianca , Khan Uzma , Bate Danielle , Davasgaium Allan , Mattu Rajan , S. Randeva Harpal

Introduction: Polycystic Ovary Syndrome (PCOS) affects 5-10% of childbearing females and, up to 20% in specific ethnic populations (i.e. South Asians and Hispanics). It is linked with a higher prevalence of obesity and metabolic dysfunction, resulting in increased risk for dyslipidaemia, impaired glucose tolerance, type 2 diabetes mellitus (T2DM) and cardiovascular diseases.Methods: This is a retrospective study of patients diagnosed with PCOS (n</em...

ea0050p224 | Diabetes and Cardiovascular | SFEBES2017

UHCW audit on SGLT2 inhibitor (SGLT2-i) use

Mytilinaiou Maria , Dimitriadis Georgios K , Davasgaium Allan , Sambrook Diane , Hewins Claire , Nalawade Nilisha , Grammatopoulos Dimitris K , Randeva Harpal S

Aim: After almost 2 centuries, SGLT2-i have made their comeback in human pharmacology through successful re-introduction in diabetes type 2 (T2D). Via restriction of renal glucose reabsorption, SGLT2-i have shown promising results. The aim of this audit was to ensure that current practice at UHCW NHS Trust is in line with the agreed national standards, whilst collecting clinical data from the use of SGLT2-i.Methods: This...

ea0050ep061 | Neoplasia, Cancer and Late Effects | SFEBES2017

Hypertestosteronemia and primary infertility from a mediastinal extragonadal germ cell tumor

Dimitriadis Georgios K , Mytilinaiou Maria , Davasgaium Allan , Sambrook Diane , Drakou Eftychia E , Hewins Claire , Nalawade Nilisha , Randeva Harpal S

A 26-year-old Caucasian male presented to the joint infertility outpatients clinic with primary infertility. His medical history included hypertrophic cardiomyopathy (HCM) due to genetically confirmed MYH7 sarcomere protein mutation, treated with implantable cardioverter-defibrillator while his partner was a healthy 24-year-old Caucasian nulliparous female. Initial investigations showed hypertestosteronemia (Testosterone: >...

ea0050p224 | Diabetes and Cardiovascular | SFEBES2017

UHCW audit on SGLT2 inhibitor (SGLT2-i) use

Mytilinaiou Maria , Dimitriadis Georgios K , Davasgaium Allan , Sambrook Diane , Hewins Claire , Nalawade Nilisha , Grammatopoulos Dimitris K , Randeva Harpal S

Aim: After almost 2 centuries, SGLT2-i have made their comeback in human pharmacology through successful re-introduction in diabetes type 2 (T2D). Via restriction of renal glucose reabsorption, SGLT2-i have shown promising results. The aim of this audit was to ensure that current practice at UHCW NHS Trust is in line with the agreed national standards, whilst collecting clinical data from the use of SGLT2-i.Methods: This...

ea0050ep061 | Neoplasia, Cancer and Late Effects | SFEBES2017

Hypertestosteronemia and primary infertility from a mediastinal extragonadal germ cell tumor

Dimitriadis Georgios K , Mytilinaiou Maria , Davasgaium Allan , Sambrook Diane , Drakou Eftychia E , Hewins Claire , Nalawade Nilisha , Randeva Harpal S

A 26-year-old Caucasian male presented to the joint infertility outpatients clinic with primary infertility. His medical history included hypertrophic cardiomyopathy (HCM) due to genetically confirmed MYH7 sarcomere protein mutation, treated with implantable cardioverter-defibrillator while his partner was a healthy 24-year-old Caucasian nulliparous female. Initial investigations showed hypertestosteronemia (Testosterone: >...

ea0077op4.2 | Metabolism, Obesity and Diabetes | SFEBES2021

3 mg Liraglutide ameliorates inflammation and improves hypothalamic regulation of energy homeostasis by modulation of Sphingosine-1-Phosphate signalling in super-responders

Spencer Lewis , Dimitriadis Georgios K , Duggirala Aparna , Bate Danielle , Davasgaium Allan , Al-Hasani Wiaam , D Miras Alexander , Le Roux Carel , Vincent Royce P , Randeva Harpal S , Tripathi Gyanendra

Background: Growing evidence suggests that hypothalamic lipid sensing plays a key role in controlling food intake, fat deposition and energy balance and that its dysregulation could lead to obesity and type 2 diabetes (T2D). Recent investigations reported that sphingosine-1-phosphate (S1P) is involved in the hypothalamic control of energy homeostasis. Intra-cerebroventricular administration of S1P decreased food intake and increased energy expenditure in rodents.<p class="...

ea0050p211 | Diabetes and Cardiovascular | SFEBES2017

Nuclear factor-kappa beta activation and monocyte-endothelial adhesion lead to chemerin induced endothelial cell inflammation

Dimitriadis Georgios K , Kaur Jaspreet , Mytilinaiou Maria , Davasgaium Allan , Sambrook Diane , Hewins Claire , Nalawade Nilisha , Miras Alexander D , Randeva Harpal S

Chemerin, a chemoattractant protein, acts via a G-protein coupled chemokine receptor, i.e. Chemokine like Receptor 1/ChemR23; levels of which are elevated in pro-inflammatory states such as obesity and type 2 diabetes mellitus (T2DM). Obesity and T2DM patients are at high risk of developing cardiovascular disorders such as atherosclerosis. We have reported that chemerin induces human endothelial cell angiogenesis and since dy...

ea0050p211 | Diabetes and Cardiovascular | SFEBES2017

Nuclear factor-kappa beta activation and monocyte-endothelial adhesion lead to chemerin induced endothelial cell inflammation

Dimitriadis Georgios K , Kaur Jaspreet , Mytilinaiou Maria , Davasgaium Allan , Sambrook Diane , Hewins Claire , Nalawade Nilisha , Miras Alexander D , Randeva Harpal S

Chemerin, a chemoattractant protein, acts via a G-protein coupled chemokine receptor, i.e. Chemokine like Receptor 1/ChemR23; levels of which are elevated in pro-inflammatory states such as obesity and type 2 diabetes mellitus (T2DM). Obesity and T2DM patients are at high risk of developing cardiovascular disorders such as atherosclerosis. We have reported that chemerin induces human endothelial cell angiogenesis and since dy...

ea0070aep374 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Liraglutide downregulates the expression of miRNA-424 in patients with obesity

Dimitriadis Georgios K , Dimitri Federica , Bate Danielle , Leca Bianca , Davasgaium Allan , Tripathi Gyanendra , Miras Alexander D , Rubino Francesco , Christian Mark , Randeva Harpal S

Aims: Liraglutide 3 mg once daily is an approved, prescription injectable Glucagon Like Peptide-1 receptor agonist that, when used with a low-calorie diet and increased physical activity, can reduce excess weight in patients with obesity. MiRNAs are small non-coding single stranded RNAs that regulate gene expression post-transcriptionally by inhibiting their mRNA target translation into proteins. MiRNAs can be secreted in the blood stream and affect the molecular pathways...

ea0099ep734 | Adrenal and Cardiovascular Endocrinology | ECE2024

Hydrocortisone vs prednisolone for treatment of adrenal insufficiency disease (HYPER-AID Study) – interim results from a single, tertiary care centre

Maria Leca Bianca , Thadani Puja , Dineesha Kumarathunga Dineesha , Wellala Vindya , Davasgaium Allan , George Rojet , Seehra Parminder , Mattu Rajan , Randeva Harpal S.

Introduction: Adrenal insufficiency (AI) requires lifelong steroid replacement therapy, traditionally with hydrocortisone (HC), which, taken in divided doses, mimics the normal daytime cortisol profile. Prednisolone, with its longer duration of action, presents a cost-effective, once-daily alternative, yet its comparative efficacy and safety profile in AI management still need to be explored. Therefore, the current study aims to assess the metabolic and cardiovascular outcomes...